# This lead from the liver revives hope against GA1

> A preclinical study published in Science Translational Medicine found that a liver-targeted treatment can curb GA1, a rare disease that can cause irreversible brain damage. The approach silences a gene involved in lysine breakdown. The article also points to blood biomarkers that could help monitor patients.

- Date: 2026-11-20 · published 2026-11-21T00:12:15.960Z
- Category: disease · region Global · magnitude low
- Page: https://feedsoft.ai/events/111270-this-lead-from-the-liver-revives-hope-against-ga1
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

This is a human medical development with no measurable effect on feed grain, protein or additive supply, demand or prices.

## Sources

- 24matins.fr: https://www.24matins.fr/cette-piste-venue-du-foie-relance-lespoir-contre-la-ga1-1424475

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.
